Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- Hematopoietic cell transplantation (HCT) donors' socioeconomic status (SES) affects recipients' health outcomes, according to a study published online July 15 in PNAS.
Lucie M. Turcotte, M.D., M.P.H., from the University of Minnesota Medical School in Minneapolis, and colleagues examined the cellular transplantability of SES-associated health risk by analyzing the health outcomes of 2,005 HCT recipients who were transplanted for hematologic malignancy at 125 U.S. transplant centers.
The researchers found that, compared to individuals transplanted from donors in the highest SES quartile, recipients transplanted with cells from donors in the lowest SES quartile experienced a 9.7 percent reduction in overall survival and a 6.6 percent increase in treatment-related mortality within three years. These results were consistent with previous research linking socioeconomic disadvantage with altered immune cell function and hematopoiesis, and indicate persistence of these effects after transfer of cells into a new host environment.
"The present data suggest that the biological impact of social disadvantage may alter hematopoietic cell function in ways that persist following transplantation into a new host," the authors write. "These results show a deep cellular penetrance of socioeconomic adversity and underscore the need for additional interventions to mitigate social health disparities."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-26 01:15
Read more
- Climate Change to Blame for Almost 1 in 5 New Dengue Infections
- Complications From Prostate Cancer Therapy Can Be Serious and Long-Term
- Skin Patch Uses 'Imperceptible' Electric Zaps to Heal Wounds Without Drugs
- ACR: Colchicine No Benefit for Painful Knee Osteoarthritis
- Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
- More Than One-Third Have ED Visit Within 90 Days Before Cancer Diagnosis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions